[go: up one dir, main page]

MX9300409A - HEXAHIDROAZEPINONAS AND TETRAHIDROBENZOAZEPINONAS SUBSTITUTED. - Google Patents

HEXAHIDROAZEPINONAS AND TETRAHIDROBENZOAZEPINONAS SUBSTITUTED.

Info

Publication number
MX9300409A
MX9300409A MX9300409A MX9300409A MX9300409A MX 9300409 A MX9300409 A MX 9300409A MX 9300409 A MX9300409 A MX 9300409A MX 9300409 A MX9300409 A MX 9300409A MX 9300409 A MX9300409 A MX 9300409A
Authority
MX
Mexico
Prior art keywords
substituted
tetrahidrobenzoazepinonas
hexahidroazepinonas
tetrahydrobenzoazepinones
haxahydroazepinones
Prior art date
Application number
MX9300409A
Other languages
Spanish (es)
Inventor
John A Lowe Iii
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9300409A publication Critical patent/MX9300409A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esta invención se refiere a nuevas haxahidroazepinonas y tetrahidrobenzoazepinonas sustituidas estos compuestos son útiles en el tratamiento y preparación de los trastornos gastrointestinales, el dolor y los trastornos de ansiedad.This invention relates to novel substituted haxahydroazepinones and tetrahydrobenzoazepinones these compounds are useful in the treatment and preparation of gastrointestinal disorders, pain and anxiety disorders.

MX9300409A 1992-01-27 1993-01-26 HEXAHIDROAZEPINONAS AND TETRAHIDROBENZOAZEPINONAS SUBSTITUTED. MX9300409A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82567792A 1992-01-27 1992-01-27

Publications (1)

Publication Number Publication Date
MX9300409A true MX9300409A (en) 1993-07-01

Family

ID=25244657

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300409A MX9300409A (en) 1992-01-27 1993-01-26 HEXAHIDROAZEPINONAS AND TETRAHIDROBENZOAZEPINONAS SUBSTITUTED.

Country Status (19)

Country Link
EP (1) EP0625145A1 (en)
JP (1) JPH07503465A (en)
KR (1) KR950700257A (en)
CN (1) CN1074903A (en)
AU (1) AU3276193A (en)
BR (1) BR9207071A (en)
CA (1) CA2117367A1 (en)
CZ (1) CZ391092A3 (en)
FI (1) FI943513A0 (en)
HU (1) HUT70496A (en)
IL (1) IL104472A0 (en)
MX (1) MX9300409A (en)
NO (1) NO942775L (en)
NZ (1) NZ245759A (en)
RU (1) RU94038063A (en)
TW (1) TW213901B (en)
WO (1) WO1993015059A1 (en)
YU (1) YU4393A (en)
ZA (1) ZA93582B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097688A1 (en) * 1993-07-14 1997-04-01 Pfizer HEXAHIDROAZEPINONAS AND TETRAHIDROBENZAZEPINONAS SUBSTITUTED.
AU6686694A (en) * 1993-07-26 1995-02-20 Pfizer Inc. Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists
AU681924B2 (en) * 1993-11-22 1997-09-11 Merck & Co., Inc. 3-acylaminobenzazepines
US5453424A (en) * 1993-11-22 1995-09-26 Merck & Co., Inc. Furanodiazepines
CA2200336C (en) * 1994-10-04 2001-12-11 Pfizer Limited Processes and intermediates for preparing 3-amino-benzo(b)azepinones
ATE210447T1 (en) * 1994-10-14 2001-12-15 Glaxo Wellcome Spa USE OF CCK-B RECEPTOR ANTAGONISTS TO TREAT SLEEP DISORDERS
DE10153348A1 (en) 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituted benzo (b) azepin-2-one compounds
MX2007016064A (en) * 2005-06-16 2008-03-10 Novartis Ag Compositions and methods for viral inhibition.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them
US4767756A (en) * 1987-07-17 1988-08-30 E. R. Squibb & Sons, Inc. 3-substituted benzazepines
EP0322779A3 (en) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Benzolactam compounds and pharmaceutical uses thereof
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck

Also Published As

Publication number Publication date
CA2117367A1 (en) 1993-08-05
WO1993015059A1 (en) 1993-08-05
NZ245759A (en) 1997-06-24
BR9207071A (en) 1995-12-05
EP0625145A1 (en) 1994-11-23
HU9402195D0 (en) 1994-09-28
KR950700257A (en) 1995-01-16
ZA93582B (en) 1994-07-27
AU3276193A (en) 1993-09-01
CZ391092A3 (en) 1994-01-19
JPH07503465A (en) 1995-04-13
FI943513A7 (en) 1994-07-26
IL104472A0 (en) 1993-05-13
TW213901B (en) 1993-10-01
FI943513L (en) 1994-07-26
FI943513A0 (en) 1994-07-26
HUT70496A (en) 1995-10-30
CN1074903A (en) 1993-08-04
NO942775D0 (en) 1994-07-26
YU4393A (en) 1996-01-09
RU94038063A (en) 1996-05-27
NO942775L (en) 1994-09-20

Similar Documents

Publication Publication Date Title
ES2116594T3 (en) BICYCLIC ANSAMICINS AND THEIR USE AS ANTITUMORAL AGENTS.
DK20892D0 (en) SEXUAL AID
MX9301634A (en) PEPTIDIC QUINUCLIDINES.
FI873280A7 (en) Therapeutic use of serotonin antagonists.
LV5824B4 (en) Psychiatric treatment of people
MY111201A (en) New imidazopyridines
FI934971A0 (en) The application of the aid scheme was carried out
KR890700313A (en) Bactericidal composition
MX9205219A (en) A TRAMADOL N-OXIDE MATERIAL, ENANTIOMERS, AND COMPOSITIONS THEREOF, AND THEIR USE
ES2157992T3 (en) ALCOXI-ALQUIL-CARBAMATOS DE IMIDAZO (1,2-A) PIRIDINES.
FI945085A7 (en) Combination neu receptor stimulating factor
FI930621A0 (en) KINOLINDERIVAT OF BIPHENYL SUBSTITUTES
MX9300409A (en) HEXAHIDROAZEPINONAS AND TETRAHIDROBENZOAZEPINONAS SUBSTITUTED.
NO903148D0 (en) HEMOREGULERINGSPEPTIDER.
FI891986A7 (en) Pharmaceutical compositions for the treatment of psoriasis
ITMI913465A0 (en) PROCEDURE FOR THE PURIFICATION OF 1.1.1-TRIFLUORO-2-FUOROETHANE
DK0545582T3 (en) Improved fish production
ES2012314A4 (en) TREATMENT OF PRECURSORY COMPOSITIONS OF POLYAMIDE.
DK87888A (en) THERAPEUTIC USE OF TINDIODDEUTEROPORFYRIN
NO982562D0 (en) Composition for the treatment of pain
FI890810A7 (en) Treatment of burns
DK0967986T3 (en) Use of human alpha1-acid glycoprotein for the preparation of a pharmaceutical composition
ES2167942T3 (en) EMPLOYMENT OF 2-6-AMINOTETRALINES APPROPRIATE SUBSTITUTES FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE THERAPEUTIC TREATMENT OF INFLAMMATORY AND / OR AUTOIMMUNE PATHOLOGIES.
FR2566265B1 (en) PHALLIC EXTENSION RING
ITMI910967V0 (en) REGULATION FOR THE DETERMINATION OF THE INTENSITY OF PAIN